Clinical trial
A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis
NCT00242853 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00242853 |
|---|---|
| Title | A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis |
| Official title | An Enabling Study to Investigate the Correlation of Biomarkers of the Activity of Inducible Nitric Oxide Synthase (iNOS) With Disease Activity and Treatment Response in Patients With Rheumatoid Arthritis(RA) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Rheumatoid Arthritis, Osteoarthritis |
| Intervention type | Procedure |
| Interventions | Power doppler ultrasonography, High frequency ultrasonography, Exhaled nitric oxide assessment |
| Enrollment | 48 |
| Start date | Oct 1, 2004 |
| First posted | Oct 21, 2005 |
| Last update posted | Oct 13, 2008 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: